Browse by author
Lookup NU author(s): Professor Mark Birch-MachinORCiD, Dr Robert EllisORCiD, Dr Jane Renwick, Professor Penny Lovat
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Early-stage cutaneous squamous cell carcinoma (cSCC) has a favourable prognosis. Metastatic disease is probably associated with chemoresistance mediated through the activation of pro-survival phosphatidylinositol 3-kinase/AKT signalling. Inhibition of activated AKT partially increases chemosensitivity but induces autophagy, the principal lysosomal mechanism for the bulk degradation and recycling of proteins and damaged organelles. The aim of the current study was to test the hypothesis that combined inhibition of AKT signalling and autophagy by the lysosomal inhibitor chloroquine increases the susceptibility to docetaxel-induced apoptosis of cSCC cells isolated from a lymph-node metastasis. Combined AKT inhibition and chloroquine treatment of MET 4 cSCC cells resulted in significantly enhanced inhibition of cell viability and apoptosis induced by clinically achievable concentrations of docetaxel (P<0.001). Inhibition of both autophagy and AKT thus represents an effective and viable therapeutic strategy to increase the cytotoxicity of docetaxel for the treatment of advanced cSCC.
Author(s): Wright TJ, McKee C, Birch-Machin MA, Ellis R, Armstrong JL, Lovat PE
Publication type: Article
Publication status: Published
Journal: Clinical and Experimental Dermatology
Year: 2013
Volume: 38
Issue: 4
Pages: 421-423
Print publication date: 01/06/2013
Online publication date: 27/03/2013
Acceptance date: 15/01/2013
ISSN (print): 0307-6938
ISSN (electronic): 1365-2230
Publisher: Wiley-Blackwell
URL: http://dx.doi.org/10.1111/ced.12138
DOI: 10.1111/ced.12138
Altmetrics provided by Altmetric
